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This short volume of the Procedia in Vaccinology highlights the three main areas that are susceptible to 
vaccines made from DNA. Pathogenic viruses, bacteria and protozoa are targets for prophylaxis by naked 
nucleic acid. In recent years it has been found that one of the most effective ways of introducing DNA 
into cells is by electroportation. This leads to enhanced expression of the protein and when the nucleic 
acid is modified so that the third base in each codon is more in line with the transformed cells codon 
repertoire, even greater enhancement of expression is observed. In addition to the DNA itself, it has been 
found that the vectors used to house the DNA , generally the Adenovirus or a non-pathogenic attenuated 
pox virus or lentivirus are not rendered ineffective as a result of previous exposure of the putative 
vaccinee to those vector viruses. These advances coupled with an increasing acceptance of oil based 
adjuvants (as opposed to the previously universal use of the salts of Aluminium) containing cytokines 
and/or Toll-Like-Receptors have opened up the field of DNA vaccines. Indeed some 4 such vaccines have 
been licensed for use in the veterinary vaccine area (West Nile virus for horses; Infectious haematopoietic 
necrosis virus in Salmon; Growth Hormone Releasing Hormone for swine and food animals and 
Melanoma in dogs – See DNA Vaccines; ready for prime time?  Michele A Kutzler and David B Weiner; 
Nature Reviews Genetics vol 9, 776-788 , 2008). 
Following these advances, it is to be expected that a new era in vaccines is about to emerge. This Procedia 
and its accompanying Supplementary Issue, edited by David Weiner, are amongst the stepping stones to 
that eventuality. 
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